Bahaa Haj Yahya

Bahaa Haj Yahya


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Medicina
Verified
Journal Article
Open access
PDF file
BYBahaa Haj Yahya
Bahaa Haj Yahya
Eli RosenfeldEli Rosenfeld
Eli Rosenfeld
Gabi ChaushuGabi Chaushu
Gabi Chaushu
Ilana KaplanIlana Kaplan
Ilana Kaplan
‪B‪Yehonatan ben-zvi‬‏
‪Yehonatan ben-zvi‬‏
YHYafit Hamzani
Yafit Hamzani
Plexiform ameloblastoma is a locally aggressive odontogenic tumor, rare in the anterior mandible. The treatment of choice is resection with 1–3 cm free margins. In most of reported cases, the affected mandible is reconstructed by autogenic bone graft or osseocutaneous microvascular free flap in order to return function and esthetics. Case description: A 2 cm diameter exophytic ameloblastoma, located in the anterior mandible of a 50-year-old male was resected and reconstructed in a unique manner—allogenic bone block, recombinant human bone morphogenetic protein (rhBMP) and xenograft particles via transcutaneous submental approach. After bone maturation, dental implants were placed and restored by fixed prosthetics. Practical implications: Mandible reconstruction modalities have a crucial influence on patient quality of life, function and esthetics. Allogenic bone block combined with rhBMP and xenograft particles can replace the traditional autogenous bone in certain circumstances. A submental transcutaneous “tent pole” approach can improve the success rate of the reconstruction procedure.

5 August 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Talia BeckerTalia Becker
Talia Becker
BYBahaa Haj Yahya
Bahaa Haj Yahya
Gabi ChaushuGabi Chaushu
Gabi Chaushu
SPShlomit Perry
Shlomit Perry
BYBahaa Haj Yahya
Bahaa Haj Yahya
We aimed to investigate the effectiveness of a support group in the management of burning mouth syndrome (BMS). The cohort included 22 adult patients with BMS who attended the oral and maxillofacial department of a tertiary medical center in 2014–2019 and agreed to participate in the study. Eleven patients were assigned to a support group and took part in 90 min sessions held once weekly for 4 weeks (a total of 4 sessions), and the remainder continued their previous individual BMS management routine (control group). All patients completed a life-quality questionnaire before and 3 months after the group sessions. Scores for each group were compared between the two time points with a Wilcoxon signed-rank test. There was a significant decrease in scores for malaise (p = 0.041), total pain (p = 0.046), and difficulty enjoying food (p = 0.026) before and after the group sessions in the study group. No significant changes were found in the control group in any of the parameters examined. A group support can alleviate pain and other clinical symptoms of BMS. Further longer-term prospective studies are needed to corroborate our findings.